XiaochuanHuo Profile Banner
Xiaochuan Huo, MD πŸ‡¨πŸ‡³ Profile
Xiaochuan Huo, MD πŸ‡¨πŸ‡³

@XiaochuanHuo

Followers
600
Following
470
Statuses
235

Neurointervention, Interventional Neurology, Beijing Anzhen Hospital, Capital Medical University,Chinese Stroke Association #ANGEL_ASPECT #ANGEL_TNK trial

Beijing, China
Joined December 2021
Don't wanna be here? Send us removal request.
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 years
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct (ANGEL-ASPECT) published online in NEJM. EVT benefits patients with a large infarct core! Thanks to ANGEL-ASPECT trial team! @dliebesk @VitorMendesPer1 @NguyenThanhMD
11
52
145
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @Lance_Tran_: Dr Huo presents POSITIVE results from Angel-TNK administering adjunct IA TNK LVO pts with eTICI 2b50 to 3, primary outcome…
0
3
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @SVN_CSA: Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded…
0
10
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @AHAScience: ANGEL-TNK results presented at #ISC25
Tweet media one
0
11
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @AHAScience: ANGEL-TNK results presented at #ISC25
Tweet media one
0
10
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @StrokeAHA_ASA: Promising results to consider with post-thrombectomy thrombolytics in LVO pts as shown in PEARL and ANGEL-TNK results… I…
0
26
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @UPensato: Two new positive trials (PEARL, ANGEL-TNK) investigating intra-arterial thrombolysis after successful recanalization, regardl…
0
13
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @HeartNews: VIDEO: Late-breaking science - Removing large brain artery clot, chased with clot-buster shot may improve stroke outcomes (L…
0
3
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 days
RT @UPensato: Take-home messages from #ISC25: ❌thrombectomy has likely achieved a ceiling effect (3 negative MeVO trial) πŸ’‰no-reflow phenom…
0
30
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
9 days
RT @AHAScience: In patients w/ acute large vessel occlusion presenting between 4.5 to 24 hours, did intra-arterial tenecteplase after succe…
0
3
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
9 days
RT @svinsociety: 🌟Join SVIN Mission Thrombectomy at the AHA/ASA International Stroke Conference!🌟 Attending the American Heart Association/…
0
14
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
2 months
RT @AshuPJadhav: Recanalization Does Not Always Equate to Reperfusion: No-Reflow Phenomenon After Successful Thrombectomy | Stroke https://…
0
32
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
3 months
@AshuPJadhav πŸ‘‹πŸ‘πŸ‘πŸ‘
0
0
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
3 months
@RaulNogueiraMD πŸ‘πŸ‘πŸ‘πŸ‘πŸ‘πŸ‘
0
0
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
4 months
RT @almuftifawaz: "You can't manage what you don't measure." β€” Peter Drucker. @SVINsociety's @MThrombectomy's latest publication allows us…
0
20
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
5 months
RT @samialkasab: @oozaidat @AlbertJYoo TESLA Trial is out!
0
7
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
5 months
RT @TudorGJovin: Check out our editorial just published in @JAMA. TESLA's unique feature is selection up to 24 hrs based on CT (ASPECTS 2-5…
0
23
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
7 months
RT @dyavagal: Abstracts open for the best stroke and Neurointerventional meeting of the year!!! Don’t believe me? Take a look at what every…
0
4
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
7 months
Association of Mismatch Profiles and Clinical Outcome from Endovascular Therapy in Large Infarct: A Post-Hoc Analysis of the ANGEL-ASPECT Trial @NguyenThanhMD @RaulNogueiraMD @AbdalkaderMD @HMasoud_ @SELECT2Trial
0
13
23
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
10 months
@McKnightBrain1 Will you center collaborate with international centers to do clinical trials?
0
0
0
@XiaochuanHuo
Xiaochuan Huo, MD πŸ‡¨πŸ‡³
10 months
0
0
1